TYMS and soft tissue sarcoma: We also observed that patients with low TYMS mRNA had significantly longer survival than the group of patients with high TYMS mRNA levels (P = 0.0018) (Fig. 3E), suggesting that TYMS may play oncogenic role in soft tissue sarcoma progression and thus, blocking TYMS expression may increase survival in patients with soft tissue sarcoma.